BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29214215)

  • 1. Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast.
    Piscuoglio S; Ng CKY; Geyer FC; Burke KA; Cowell CF; Martelotto LG; Natrajan R; Popova T; Maher CA; Lim RS; Bruijn I; Mariani O; Norton L; Vincent-Salomon A; Weigelt B; Reis-Filho JS
    NPJ Breast Cancer; 2017; 3():48. PubMed ID: 29214215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.
    Ng CKY; Piscuoglio S; Geyer FC; Burke KA; Pareja F; Eberle CA; Lim RS; Natrajan R; Riaz N; Mariani O; Norton L; Vincent-Salomon A; Wen YH; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2017 Jul; 23(14):3859-3870. PubMed ID: 28153863
    [No Abstract]   [Full Text] [Related]  

  • 3. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].
    Weigelt B; Ng CK; Shen R; Popova T; Schizas M; Natrajan R; Mariani O; Stern MH; Norton L; Vincent-Salomon A; Reis-Filho JS
    Mod Pathol; 2015 Mar; 28(3):340-51. PubMed ID: 25412848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.
    Moukarzel LA; Ferrando L; Da Cruz Paula A; Brown DN; Geyer FC; Pareja F; Piscuoglio S; Papanastasiou AD; Fusco N; Marchiò C; Abu-Rustum NR; Murali R; Brogi E; Wen HY; Norton L; Soslow RA; Vincent-Salomon A; Reis-Filho JS; Weigelt B
    Mol Oncol; 2021 Apr; 15(4):1024-1039. PubMed ID: 33021035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.
    da Silva EM; Selenica P; Vahdatinia M; Pareja F; Da Cruz Paula A; Ferrando L; Gazzo AM; Dopeso H; Ross DS; Bakhteri A; Riaz N; Chandarlapaty S; Razavi P; Norton L; Wen HY; Brogi E; Weigelt B; Zhang H; Reis-Filho JS
    NPJ Breast Cancer; 2021 Apr; 7(1):43. PubMed ID: 33863915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
    Hennessy BT; Gonzalez-Angulo AM; Stemke-Hale K; Gilcrease MZ; Krishnamurthy S; Lee JS; Fridlyand J; Sahin A; Agarwal R; Joy C; Liu W; Stivers D; Baggerly K; Carey M; Lluch A; Monteagudo C; He X; Weigman V; Fan C; Palazzo J; Hortobagyi GN; Nolden LK; Wang NJ; Valero V; Gray JW; Perou CM; Mills GB
    Cancer Res; 2009 May; 69(10):4116-24. PubMed ID: 19435916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis.
    Weigelt B; Kreike B; Reis-Filho JS
    Breast Cancer Res Treat; 2009 Sep; 117(2):273-80. PubMed ID: 18815879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.
    McCart Reed AE; Kalaw E; Nones K; Bettington M; Lim M; Bennett J; Johnstone K; Kutasovic JR; Saunus JM; Kazakoff S; Xu Q; Wood S; Holmes O; Leonard C; Reid LE; Black D; Niland C; Ferguson K; Gresshoff I; Raghavendra A; Harvey K; Cooper C; Liu C; Kalinowski L; Reid AS; Davidson M; Pearson JV; Pathmanathan N; Tse G; Papadimos D; Pathmanathan R; Harris G; Yamaguchi R; Tan PH; Fox SB; O'Toole SA; Simpson PT; Waddell N; Lakhani SR
    J Pathol; 2019 Feb; 247(2):214-227. PubMed ID: 30350370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma.
    Krings G; Chen YY
    Mod Pathol; 2018 Nov; 31(11):1661-1674. PubMed ID: 29946183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-exome analysis of metaplastic breast carcinomas with extensive osseous differentiation.
    Beca F; Sebastiao APM; Pareja F; Dessources K; Lozada JR; Geyer F; Selenica P; Zeizafoun N; Wen HY; Norton L; Brogi E; Weigelt B; Reis-Filho JS
    Histopathology; 2020 Aug; 77(2):321-326. PubMed ID: 32043609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma.
    González-Martínez S; Pérez-Mies B; Carretero-Barrio I; Palacios-Berraquero ML; Perez-García J; Cortés J; Palacios J
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32650408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma.
    Lien HC; Hsu CL; Lu YS; Chen TW; Chen IC; Li YC; Huang CS; Cheng AL; Lin CH
    Breast Cancer Res; 2023 Jan; 25(1):11. PubMed ID: 36707876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1.
    Joneja U; Vranic S; Swensen J; Feldman R; Chen W; Kimbrough J; Xiao N; Reddy S; Palazzo J; Gatalica Z
    J Clin Pathol; 2017 Mar; 70(3):255-259. PubMed ID: 27531819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 7 aneusomy in metaplastic breast carcinomas with chondroid, squamous, and spindle-cell differentiation.
    Gwin K; Lezon-Geyda K; Harris L; Tavassoli FA
    Int J Surg Pathol; 2011 Feb; 19(1):20-5. PubMed ID: 19411277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of metaplastic breast carcinoma via next-generation sequencing.
    Zhai J; Giannini G; Ewalt MD; Zhang EY; Invernizzi M; Niland J; Lai LL
    Hum Pathol; 2019 Apr; 86():85-92. PubMed ID: 30537493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Unique Surgical Case of Mixed Metaplastic Breast Carcinoma With Heterologous Mesenchymal Differentiation and Conventional Adenocarcinomatous Elements.
    Okanemasa Y; Shioya A; Kumagai M; Takata M; Tsubata Y; Han J; Terauchi T; Morioka E; Inokuchi M; Yamada S
    Cureus; 2024 Mar; 16(3):e55926. PubMed ID: 38601424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.
    Vincent-Salomon A; Gruel N; Lucchesi C; MacGrogan G; Dendale R; Sigal-Zafrani B; Longy M; Raynal V; Pierron G; de Mascarel I; Taris C; Stoppa-Lyonnet D; Pierga JY; Salmon R; Sastre-Garau X; Fourquet A; Delattre O; de Cremoux P; Aurias A
    Breast Cancer Res; 2007; 9(2):R24. PubMed ID: 17417968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unique presentation of metaplastic breast carcinoma, NOS: A case report.
    Mremi A; Mwakyembe TE; Suleman M; Lodhia J
    Clin Case Rep; 2023 Dec; 11(12):e8320. PubMed ID: 38089485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
    Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Mamessier E; Adélaïde J; Debono S; Houvenaeghel G; Maraninchi D; Viens P; Charpin C; Jacquemier J; Birnbaum D
    Cancer Res; 2006 May; 66(9):4636-44. PubMed ID: 16651414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin expression in breast cancer: high or low, what to expect?
    Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
    Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.